Adalimumab in Crohn’s disease

por Van Assche, Gert, Vermeire, Séverine, Rutgeerts, Paul
Publicado 2007

Vaccination and infection prevention in inflammatory bowel disease

por Vermeire, Severine, Van Assche, Gert, Rutgeerts, Paul
Publicado 2010

Infliximab: the evidence for its place in therapy in ulcerative colitis

por Van Assche, Gert, Vermeire, Séverine, Rutgeerts, Paul
Publicado 2007

Balloon dilatation of ileo-colonic anastomosis in Crohn’s disease

por Katsanos, Konstantinos H., Rutgeerts, Paul J., Assche, Gert Van, Tsianos, Epameinondas V.
Publicado 2012

Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFα, improves health-related quality of life in patients with moderate to severe Crohn’s disease

por Rutgeerts, Paul, Schreiber, Stefan, Feagan, Brian, Keininger, Dorothy L., O’Neil, Liz, Fedorak, Richard N.
Publicado 2007

Metabolic Profiling of the Impact of Oligofructose-Enriched Inulin in Crohn's Disease Patients: A Double-Blinded Randomized Controlled Trial

por De Preter, Vicky, Joossens, Marie, Ballet, Vera, Shkedy, Ziv, Rutgeerts, Paul, Vermeire, Severine, Verbeke, PhD, Kristin
Publicado 2013

Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants

por Cleynen, Isabelle, Mahachie John, Jestinah M., Henckaerts, Liesbet, Van Moerkercke, Wouter, Rutgeerts, Paul, Van Steen, Kristel, Vermeire, Severine
Publicado 2010

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the A...

por Cornillie, Freddy, Hanauer, Stephen B, Diamond, Robert H, Wang, Jianping, Tang, Kezhen L, Xu, Zhenhua, Rutgeerts, Paul, Vermeire, Séverine
Publicado 2014

A phase II study of laquinimod in Crohn's disease

por D'Haens, Geert, Sandborn, William J, Colombel, Jean Frederic, Rutgeerts, Paul, Brown, Kurt, Barkay, Hadas, Sakov, Anat, Haviv, Asi, Feagan, Brian G
Publicado 2015

Assessment of the Microbiota in Microdissected Tissues of Crohn's Disease Patients

por De Hertogh, Gert, Lemmens, Bart, Verhasselt, Peter, de Hoogt, Ronald, Sagaert, Xavier, Joossens, Marie, Van Assche, Gert, Rutgeerts, Paul, Vermeire, Severine, Aerssens, Jeroen
Publicado 2012

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn’s Disease Studies

por Panaccione, Remo, Löfberg, Robert, Rutgeerts, Paul, Sandborn, William J, Schreiber, Stefan, Berg, Sofie, Maa, Jen-Fue, Petersson, Joel, Robinson, Anne M, Colombel, Jean-Frederic
Publicado 2019

A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease

por Lichtenstein, Gary R, Rutgeerts, Paul, Sandborn, William J, Sands, Bruce E, Diamond, Robert H, Blank, Marion, Montello, Jennifer, Tang, Linda, Cornillie, Freddy, Colombel, Jean-Frédéric
Publicado 2012

Genetic Evidence Supporting the Association of Protease and Protease Inhibitor Genes with Inflammatory Bowel Disease: A Systematic Review

por Cleynen, Isabelle, Jüni, Peter, Bekkering, Geertruida E., Nüesch, Eveline, Mendes, Camila T., Schmied, Stefanie, Wyder, Stefan, Kellen, Eliane, Villiger, Peter M., Rutgeerts, Paul, Vermeire, Séverine, Lottaz, Daniel
Publicado 2011

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

por Gibson, Peter R, Feagan, Brian G, Sandborn, William J, Marano, Colleen, Strauss, Richard, Johanns, Jewel, Padgett, Lakshmi, Collins, Judith, Tarabar, Dino, Hebzda, Zbigniew, Rutgeerts, Paul, Reinisch, Walter
Publicado 2016

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Mai...

por Adedokun, Omoniyi J., Xu, Zhenhua, Marano, Colleen W., Strauss, Richard, Zhang, Hongyan, Johanns, Jewel, Zhou, Honghui, Davis, Hugh M., Reinisch, Walter, Feagan, Brian G., Rutgeerts, Paul, Sandborn, William J.
Publicado 2017

Characterisation of Mucosal Healing with Adalimumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease: Results from the EXTEND Trial

por Reinisch, Walter, Colombel, Jean-Frédéric, D’Haens, Geert, Sandborn, William J., Rutgeerts, Paul, Geboes, Karel, Petersson, Joel, Eichner, Samantha, Zhou, Qian, Robinson, Anne M., Read, Holly A., Thakkar, Roopal
Publicado 2017

Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment

por Arijs, Ingrid, De Hertogh, Gert, Lemaire, Katleen, Quintens, Roel, Van Lommel, Leentje, Van Steen, Kristel, Leemans, Peter, Cleynen, Isabelle, Van Assche, Gert, Vermeire, Séverine, Geboes, Karel, Schuit, Frans, Rutgeerts, Paul
Publicado 2009

Association of a Functional Variant in the Wnt Co-Receptor LRP6 with Early Onset Ileal Crohn's Disease

por Koslowski, Maureen J., Teltschik, Zora, Beisner, Julia, Schaeffeler, Elke, Wang, Guoxing, Kübler, Irmgard, Gersemann, Michael, Cooney, Rachel, Jewell, Derek, Reinisch, Walter, Vermeire, Séverine, Rutgeerts, Paul, Schwab, Matthias, Stange, Eduard F., Wehkamp, Jan
Publicado 2012

The safety of vedolizumab for ulcerative colitis and Crohn's disease

por Colombel, Jean-Frédéric, Sands, Bruce E, Rutgeerts, Paul, Sandborn, William, Danese, Silvio, D'Haens, Geert, Panaccione, Remo, Loftus, Edward V, Sankoh, Serap, Fox, Irving, Parikh, Asit, Milch, Catherine, Abhyankar, Brihad, Feagan, Brian G
Publicado 2017

Unique Gene Expression and MR T(2) Relaxometry Patterns Define Chronic Murine Dextran Sodium Sulphate Colitis as a Model for Connective Tissue Changes in Human Crohn’s Disease

por Breynaert, Christine, Dresselaers, Tom, Perrier, Clémentine, Arijs, Ingrid, Cremer, Jonathan, Van Lommel, Leentje, Van Steen, Kristel, Ferrante, Marc, Schuit, Frans, Vermeire, Séverine, Rutgeerts, Paul, Himmelreich, Uwe, Ceuppens, Jan L., Geboes, Karel, Van Assche, Gert
Publicado 2013